These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 17950446)

  • 1. Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics.
    Quigley EM
    Gastroenterol Clin North Am; 2007 Sep; 36(3):735-48, xi. PubMed ID: 17950446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management.
    Quigley EM
    J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of probiotics in IBS.
    Quigley EM
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S85-90. PubMed ID: 18542036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating irritable bowel syndrome with probiotics: the evidence.
    Parkes GC; Sanderson JD; Whelan K
    Proc Nutr Soc; 2010 May; 69(2):187-94. PubMed ID: 20236566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial overgrowth as a cause of irritable bowel syndrome.
    Riordan SM; Kim R
    Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics.
    Gupta V; Garg R
    Indian J Med Microbiol; 2009; 27(3):202-9. PubMed ID: 19584499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of gastrointestinal bacterial overgrowth.
    Husebye E
    Chemotherapy; 2005; 51 Suppl 1():1-22. PubMed ID: 15855746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics.
    Madden JA; Hunter JO
    Br J Nutr; 2002 Sep; 88 Suppl 1():S67-72. PubMed ID: 12215182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics in functional gastrointestinal disorders: what are the facts?
    Quigley EM
    Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date.
    Quigley EM; Flourie B
    Neurogastroenterol Motil; 2007 Mar; 19(3):166-72. PubMed ID: 17300285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical evaluation of probiotic activity of lactic acid bacteria and their effects.
    Heczko PB; Strus M; Kochan P
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():5-12. PubMed ID: 17242483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotics in gastrointestinal disorders.
    Quigley EM
    Hosp Pract (1995); 2010 Nov; 38(4):122-9. PubMed ID: 21068536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1.
    Pimentel M
    Am J Gastroenterol; 2010 Apr; 105(4):718-21. PubMed ID: 20372119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy.
    Camilleri M
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S123-5. PubMed ID: 18806702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.
    Quigley EM
    Nutr Clin Pract; 2012 Apr; 27(2):195-200. PubMed ID: 22127952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 51-year-old with irritable bowel syndrome: test or treat for bacterial overgrowth?
    Quigley EM
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1140-3. PubMed ID: 17916541
    [No Abstract]   [Full Text] [Related]  

  • 19. [Postinfectious irritable bowel syndrome].
    Döbrönte Z; Lakner L; Sarang K
    Orv Hetil; 2006 Oct; 147(43):2077-80. PubMed ID: 17297754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and microflora.
    Pimentel M; Chang C
    Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.